Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes
Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of hypertriglyceridemia in Type II diabetics. The drug was discovered...
Roche Vitamin Plant
Roche's latest vitamin plant is located in Taishan (Shanghai) which is in the north eastern part of the Peoples' Republic of China. Roche Holding...
Health ministry turns down SLAs’ demand for amending D&C Rules to define role of SLAs in monitoring clinical trials
3rd February 2014, India - The Union health ministry of India has turned down some of the state drug controllers' demand for an amendment...
Cancer Aid Society urges govt to relax norms on oral morphine to provide relief to cancer patients
The Cancer Aid Society of India has urged the government to relax norms with respect to availability and accessibility of oral morphine in the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...